Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis.
about
Reactive oxygen species, apoptosis, antimicrobial peptides and human inflammatory diseasesStenotrophomonas maltophilia: an emerging global opportunistic pathogenPCR-based rapid genotyping of Stenotrophomonas maltophilia isolates.Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients.Role of excessive inflammatory response to Stenotrophomonas maltophilia lung infection in DBA/2 mice and implications for cystic fibrosisPhenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia.Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis.Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degreesType II Secretion-Dependent Degradative and Cytotoxic Activities Mediated by Stenotrophomonas maltophilia Serine Proteases StmPr1 and StmPr2Characteristics of Aspergillus fumigatus in Association with Stenotrophomonas maltophilia in an In Vitro Model of Mixed Biofilm.Stenotrophomonas maltophilia encodes a type II protein secretion system that promotes detrimental effects on lung epithelial cells.Antimicrobial and antibiofilm activity of secondary metabolites of lichens against methicillin-resistant Staphylococcus aureus strains from cystic fibrosis patients.Stenotrophomonas maltophilia Phenotypic and Genotypic Diversity during a 10-year Colonization in the Lungs of a Cystic Fibrosis Patient.In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections.Cooperative pathogenicity in cystic fibrosis: Stenotrophomonas maltophilia modulates Pseudomonas aeruginosa virulence in mixed biofilm.Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.
P2860
Q26823282-803FE2A4-36A4-4F39-A4FC-9ED26A4371C2Q26995336-81300B86-F4D8-4D16-BF94-6E7726203706Q33386217-05D285C5-1D87-4414-9A0E-5B0396913A03Q33550582-393E1864-D04C-4B6C-867D-F32D5F177431Q33877139-1A004143-5E09-41A9-B675-733E438919ABQ33950924-F21D3C9D-E487-4043-B8C2-A774F3300F1EQ34348146-44E5E25A-41DA-4ABE-9126-D2075DAEFD4EQ35106279-B88E3A60-9BCB-4158-817B-0B266F3F5E9DQ35199103-20CAD15A-D48E-4D81-8364-2ACE372A08F9Q36053562-7DCE167B-30C2-42AB-AE6C-2526E2E43F07Q36199673-564FD392-0E65-4673-B0AB-E3D76CF7C498Q37123787-15A4BBB4-BD44-4D97-A9A0-0FCD044B457FQ39474102-E372A10E-3CC7-4457-8518-C5B6D413ECCDQ40504881-444AEAC9-755B-42E5-A1AB-C524518488D4Q40642439-A75479FE-14DA-4049-8B31-9FBFF1C8BE50Q40964077-A9D46DDA-53B6-4DD1-8C98-5F36A9726534Q47126542-A714B0F3-B47B-44B2-93D3-F4217F2AFA22
P2860
Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Molecular characterization of ...... s affected by cystic fibrosis.
@en
type
label
Molecular characterization of ...... s affected by cystic fibrosis.
@en
prefLabel
Molecular characterization of ...... s affected by cystic fibrosis.
@en
P2093
P2860
P1476
Molecular characterization of ...... s affected by cystic fibrosis.
@en
P2093
A Petrucca
E Fiscarelli
F Del Chierico
G Di Bonaventura
G Prosseda
M Casalino
M G Ammendolia
P2860
P304
P356
10.1177/039463200702000311
P577
2007-07-01T00:00:00Z